Susquehanna International Group, LLP Brainstorm Cell Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 23,000 shares of BCLI stock, worth $52,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,000

Previous 23,400 1.71%

Holding current value

$52,439

Previous $7,000 28.57%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.28 - $0.66 $479 - $1,130	1,713 Added 6.9%	26,544 $14,000
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.4 $3,724 - $9,932	24,831 New	24,831 $6,000
Q2 2023 Aug 11, 2023	BUY	$2.0 - $3.2 $208,092 - $332,947	104,046 Added 25.9%	505,799 $1.04 Million
Q1 2023 May 16, 2023	BUY	$1.43 - $3.3 $422,825 - $975,750	295,682 Added 278.76%	401,753 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$1.37 - $4.42 $145,317 - $468,833	106,071 New	106,071 $173,000
Q2 2022 Aug 15, 2022	SELL	$2.71 - $3.6 $214,840 - $285,397	-79,277 Reduced 83.8%	15,323 $42,000
Q1 2022 May 16, 2022	BUY	$2.92 - $4.19 $162,261 - $232,834	55,569 Added 142.37%	94,600 $318,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $770,832 - $1 Million	-245,488 Reduced 86.28%	39,031 $129,000
Q1 2021 May 17, 2021	SELL	$3.46 - $7.88 $298,009 - $678,704	-86,130 Reduced 23.24%	284,519 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $1.22 Million - $5.41 Million	305,343 Added 467.56%	370,649 $1.68 Million
Q4 2019 Feb 14, 2020	SELL	$3.62 - $4.29 $119,496 - $141,612	-33,010 Reduced 33.58%	65,306 $280,000
Q3 2019 Nov 14, 2019	BUY	$3.54 - $4.48 $60,912 - $77,087	17,207 Added 21.21%	98,316 $383,000
Q2 2019 Aug 16, 2019	BUY	$3.59 - $4.3 $8,350 - $10,001	2,326 Added 2.95%	81,109 $320,000
Q2 2019 Aug 14, 2019	BUY	$3.59 - $4.3 $103,284 - $123,711	28,770 Added 57.53%	78,783 $311,000
Q1 2019 May 15, 2019	BUY	$3.37 - $4.34 $74,052 - $95,367	21,974 Added 78.37%	50,013 $217,000
Q4 2018 Feb 14, 2019	BUY	$2.98 - $3.9 $26,098 - $34,156	8,758 Added 45.42%	28,039 $100,000
Q3 2018 Nov 14, 2018	BUY	$3.73 - $4.38 $28,459 - $33,419	7,630 Added 65.49%	19,281 $74,000
Q2 2018 Aug 14, 2018	BUY	$3.12 - $5.19 $36,351 - $60,468	11,651 New	11,651 $45,000
Q1 2018 May 15, 2018	SELL	$3.01 - $3.77 $161,405 - $202,158	-53,623 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.96 - $4.42 $52,483 - $78,371	17,731 Added 49.4%	53,623 $210,000
Q3 2017 Nov 20, 2017	BUY	$3.98 - $4.36 $142,850 - $156,489	35,892	35,892 $148,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

10.8M

Call Options Held

160K

Put Options Held

30.5K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Brainstorm Cell Therapeutics Inc. Transaction History